Ferdinand H Bahlmann

Summary

Affiliation: Hannover Medical School
Country: Germany

Publications

  1. ncbi Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists
    Ferdinand H Bahlmann
    Division of Nephrology, Department of Internal Medicine, Hanover Medical School, Hanover, Germany
    Hypertension 45:526-9. 2005
  2. ncbi Erythropoietin regulates endothelial progenitor cells
    Ferdinand H Bahlmann
    Department of Internal Medicine, Hannover Medical School, Carl Neuberg Strasse 1, 30625, Hannover, Germany
    Blood 103:921-6. 2004
  3. ncbi Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin
    Ferdinand H Bahlmann
    Division of Nephrology, Department of Internal Medicine, Hanover Medical School, Hanover, Germany
    Kidney Int 64:1648-52. 2003
  4. ncbi Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure
    Ferdinand H Bahlmann
    Department of Internal Medicine, Hannover Medical School, Carl Neuberg Strasse 1, 30625 Hannover, Germany
    Circulation 110:1006-12. 2004
  5. ncbi Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy
    Sajoscha A Sorrentino
    Klinik für Kardiologie und Angiologie, Medizinische Hochschule Hannover, Hannover, Germany
    Circulation 121:110-22. 2010
  6. ncbi Mechanisms of disease: erythropoietin--an old hormone with a new mission?
    Danilo Fliser
    Hannover Medical School, Hannover, Germany
    Nat Clin Pract Cardiovasc Med 3:563-72. 2006
  7. ncbi Endothelial progenitor cells and cardiovascular events in patients with chronic kidney disease--a prospective follow-up study
    Johan Lorenzen
    Division of Nephrology, Department of Internal Medicine, Hannover Medical School, Hannover, Germany
    PLoS ONE 5:e11477. 2010
  8. ncbi Kidney graft function determines endothelial progenitor cell number in renal transplant recipients
    Kirsten de Groot
    Division of Nephrology, Department of Internal Medicine, Hannover Medical School, 30625 Hannover, Germany
    Transplantation 79:941-5. 2005
  9. ncbi EPO: renoprotection beyond anemia correction
    Danilo Fliser
    Division of Nephrology, Department of Internal Medicine, Hannover Medical School, Carl Neuberg Strasse 1, 30625 Hannover, Germany
    Pediatr Nephrol 21:1785-9. 2006
  10. ncbi Cellular and molecular mechanisms of tissue protection by lipophilic calcium channel blockers
    Jan Menne
    Department of Internal Medicine, Medical School Hannover, Carl Neuberg Strasse 1, Hannover 30625, Germany
    FASEB J 20:994-6. 2006

Collaborators

Detail Information

Publications18

  1. ncbi Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists
    Ferdinand H Bahlmann
    Division of Nephrology, Department of Internal Medicine, Hanover Medical School, Hanover, Germany
    Hypertension 45:526-9. 2005
    ..Angiotensin II receptor antagonists increase the number of regenerative EPCs in patients with type 2 diabetes mellitus. This action may be of therapeutic relevance contributing to their beneficial cardiovascular effects...
  2. ncbi Erythropoietin regulates endothelial progenitor cells
    Ferdinand H Bahlmann
    Department of Internal Medicine, Hannover Medical School, Carl Neuberg Strasse 1, 30625, Hannover, Germany
    Blood 103:921-6. 2004
    ..Erythropoietin increases the number of functionally active EPCs in humans. Administration of rhEPO or EPO analogs may open new therapeutic strategies in regenerative cardiovascular medicine...
  3. ncbi Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin
    Ferdinand H Bahlmann
    Division of Nephrology, Department of Internal Medicine, Hanover Medical School, Hanover, Germany
    Kidney Int 64:1648-52. 2003
    ..We tested the hypothesis that darbepoetin alfa [i.e., a recombinant analogue of the cytokine erythropoietin (EPO)] stimulates proliferation and differentiation of EPCs...
  4. ncbi Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure
    Ferdinand H Bahlmann
    Department of Internal Medicine, Hannover Medical School, Carl Neuberg Strasse 1, 30625 Hannover, Germany
    Circulation 110:1006-12. 2004
    ....
  5. ncbi Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy
    Sajoscha A Sorrentino
    Klinik für Kardiologie und Angiologie, Medizinische Hochschule Hannover, Hannover, Germany
    Circulation 121:110-22. 2010
    ..Moreover, in diabetic patients, we examined the impact of extended-release (ER) niacin therapy on the endothelial effects of HDL...
  6. ncbi Mechanisms of disease: erythropoietin--an old hormone with a new mission?
    Danilo Fliser
    Hannover Medical School, Hannover, Germany
    Nat Clin Pract Cardiovasc Med 3:563-72. 2006
    ..This review article summarizes the present knowledge on the cardiovascular and renal protective effects of erythropoietin and discusses the possible underlying mechanisms...
  7. ncbi Endothelial progenitor cells and cardiovascular events in patients with chronic kidney disease--a prospective follow-up study
    Johan Lorenzen
    Division of Nephrology, Department of Internal Medicine, Hannover Medical School, Hannover, Germany
    PLoS ONE 5:e11477. 2010
    ..Endothelial progenitor cells (EPCs) mediate vascular repair and regeneration. Their number in peripheral blood is related to cardiovascular events in individuals with normal renal function...
  8. ncbi Kidney graft function determines endothelial progenitor cell number in renal transplant recipients
    Kirsten de Groot
    Division of Nephrology, Department of Internal Medicine, Hannover Medical School, 30625 Hannover, Germany
    Transplantation 79:941-5. 2005
    ..In uremic patients, the number of functionally active EPCs is reduced. Thus, we assessed EPCs in stable patients 6 months or more after renal transplantation...
  9. ncbi EPO: renoprotection beyond anemia correction
    Danilo Fliser
    Division of Nephrology, Department of Internal Medicine, Hannover Medical School, Carl Neuberg Strasse 1, 30625 Hannover, Germany
    Pediatr Nephrol 21:1785-9. 2006
    ....
  10. ncbi Cellular and molecular mechanisms of tissue protection by lipophilic calcium channel blockers
    Jan Menne
    Department of Internal Medicine, Medical School Hannover, Carl Neuberg Strasse 1, Hannover 30625, Germany
    FASEB J 20:994-6. 2006
    ..These effects may result, at least in part, from inhibition of tissue inflammation as well as improved NO bioavailability. Modulation of PKC activity may be an important underlying intracellular mechanism...
  11. ncbi Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone
    Sajoscha A Sorrentino
    Abteilung Kardiologie und Angiologie, Medizinische Hochschule Hannover, Hannover, Germany
    Circulation 116:163-73. 2007
    ....
  12. ncbi Erythropoietin: is it more than correcting anaemia?
    Ferdinand H Bahlmann
    Division of Nephrology, Department of Internal Medicine, Hannover Medical School, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany
    Nephrol Dial Transplant 19:20-2. 2004
  13. ncbi Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice
    Jan Menne
    Phenos, Hannover, Germany
    Diabetes 53:2101-9. 2004
    ..Therefore, PKC-alpha is a possible therapeutic target for the prevention of diabetic albuminuria...
  14. ncbi Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase
    Ulf Landmesser
    Abteilung Kardiologie und Angiologie, Medizinische Hochschule Hannover, Hannover, Germany
    Circulation 110:1933-9. 2004
    ....
  15. ncbi Liver regeneration in a retrorsine/CCl4-induced acute liver failure model: do bone marrow-derived cells contribute?
    Marc H Dahlke
    Centenary Institute for Cancer Medicine and Cell Biology and Department for Hepatobiliary and Transplantation Surgery, University of Sydney, Royal Prince Alfred Hospital, Missenden Road, Camperdown, Sydney, NSW 2050, Australia
    J Hepatol 39:365-73. 2003
    ..Adult bone marrow contains progenitors capable of generating hepatocytes. Here a new liver failure model is introduced to assess whether bone marrow-derived progeny contribute to liver regeneration after acute hepatotoxic liver failure...
  16. ncbi Circulating endothelial cells: life, death, detachment and repair of the endothelial cell layer
    Alexander Woywodt
    Nephrol Dial Transplant 17:1728-30. 2002
  17. ncbi Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells
    Dirk H Walter
    Department of Medicine (Cardiovascular Research, St Elizabeth's Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA
    Circulation 105:3017-24. 2002
    ....
  18. ncbi Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth
    Rudolf Kirchmair
    Division of Cardiovascular Research, St Elizabeth s Medical Center, Tufts University School of Medicine, Boston, Mass 02135, USA
    Circulation 111:2662-70. 2005
    ..The pathogenic basis for toxic neuropathies induced by chemotherapeutic agents has not been completely elucidated...